Google
Apple
English (UK)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BAYER AG |
Market Closed -
Other stock markets
|
|
Pre-market 02:34:55 | ||
| 31.7 EUR | +2.85% | 31.89 | +0.59% | |
| 06:37am | Bayer Faces $3.5 Million Penalty in US Roundup Cancer Case | MT |
| 12:53am | Bayer ordered to pay $3.5 million in latest Roundup weedkiller trial | RE |
| Sales 2023 * | 47.65B 51.4B 69.74B | Sales 2024 * | 48.51B 52.33B 71B | Capitalization | 31.15B 33.6B 45.59B |
|---|---|---|---|---|---|
| Net income 2023 * | -860M -928M -1.26B | Net income 2024 * | 3.67B 3.96B 5.37B | EV / Sales 2023 * | 1,42x |
| Net Debt 2023 * | 36.43B 39.3B 53.32B | Net Debt 2024 * | 34.33B 37.03B 50.24B | EV / Sales 2024 * | 1,35x |
| P/E ratio 2023 * | -11,6x | P/E ratio 2024 * | 9,16x | Employees | 100,873 |
| Yield 2023 * | 6,98% | Yield 2024 * | 6,86% | Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.60% | ||
| 1 week | +3.76% | ||
| Current month | +1.10% | ||
| 1 month | -24.62% | ||
| 3 months | -37.40% | ||
| 6 months | -39.17% | ||
| Current year | -34.39% |
1 week
30.35
31.80
1 month
30.2242.58
Current year
30.2265.66
1 year
30.2265.66
3 years
30.2267.99
5 years
30.2278.34
10 years
30.22146.45
| Managers | Title | Age | Since |
|---|---|---|---|
Wolfgang Nickl
DFI | Director of Finance/CFO | 54 | 2018 |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 54 | 2020 |
Itziar Canamasas
PRN | Corporate Officer/Principal | 49 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 2017 |
| Director/Board Member | 67 | 2017 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 2021 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 9.77% | 54 M€ | -.--% | - | |
| 9.71% | 489 M€ | -.--% | ||
| 9.46% | 10 M€ | -15.59% | ||
| 6.69% | 861 M€ | -14.78% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-05 | 31.7 | +2.85% | 4,058,062 |
| 23-12-04 | 30.82 | -0.92% | 3,805,359 |
| 23-12-01 | 31.11 | -0.80% | 4,898,592 |
| 23-11-30 | 31.36 | +2.25% | 6,045,158 |
| 23-11-29 | 30.67 | +0.38% | 4,747,728 |
Delayed Quote Xetra, December 05, 2023 at 11:42 am
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
Sector
Pharmaceuticals
Calendar
2024-03-05
- Q4 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
31.7EUR
Average target price
50.29EUR
Spread / Average Target
+58.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.39% | 33 619 M $ | |
| +60.77% | 529 B $ | |
| +46.50% | 444 B $ | |
| -10.25% | 382 B $ | |
| -4.25% | 269 B $ | |
| -10.54% | 255 B $ | |
| -13.61% | 231 B $ | |
| +1.76% | 200 B $ | |
| -9.57% | 198 B $ | |
| -43.23% | 164 B $ |
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition